Method and system for evaluating curative effect image of liver cancer rupture bleeding embolism treatment
By combining initial computer segmentation with doctor-interactive correction, and utilizing the visualization interface and multidimensional feature extraction of enhanced CT image data, the problem of distinguishing between active tumors and non-tumor components after hepatocellular carcinoma rupture and hemorrhage embolization treatment has been solved, enabling more accurate efficacy assessment and safer treatment plan formulation.
Patent Information
- Application Number
- CN202511794148.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-02
- Publication Date
- 2026-03-06
AI Technical Summary
Traditional image processing methods struggle to accurately distinguish between active tumor tissue and non-tumor components after hemorrhage embolization treatment for liver cancer rupture, leading to misjudgment of treatment efficacy and potentially delaying or over-treating the condition.
Combining preliminary computer-generated classification with the experience of medical experts, and through an interactive correction mechanism, the boundaries of the lesion area are adjusted in real time using a visualization interface for enhanced CT image data and multi-dimensional feature extraction, generating an assessment report.
This improves the accuracy of efficacy assessment in embolization treatment of ruptured liver cancer, avoids the risk of misdiagnosis and mistreatment, and provides more precise treatment plans and prognostic criteria.
Smart Images

Figure CN121617569A_ABST